Stem Cells (Heart)

This study involves an investigational study procedure of injecting allogeneic (donor) stem cells into the heart muscle of people with heart failure to see if it may improve the function of their heart. More »

The goal of this study is to determine the effectiveness of injecting one’s own stem cells, delivered by catheter (tube) into region of the heart with poor blood flow. Stem cells are simple cells produced by the bone marrow that can develop into blood cells or other types of cells. More »

This study is testing the safety and effectiveness of giving a person’s own stem cells 2 to 3 weeks after a heart attack. Stem cells are simple cells that can help your injured tissues repair themselves and may help grow new blood vessels. More »

Erythropoietin (pronounced ĭ-rĭth'rō-poi-ē'tĭn) is a protein found naturally in your body, which regulates the number of red blood cells (the cells that carry oxygen) in your blood. Epoetin alfa (Procrit®) is the name of the man-made erythropoietin drug, and it has been approved by the FDA for the treatment of low red blood cell counts (anemia). Therefore, in this study, we would like to evaluate whether Epoetin alfa has these same beneficial effects in people with heart attacks. More »